Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles
- PMID: 1362183
- PMCID: PMC1421720
Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles
Abstract
The induction of CD4+ T-helper (Th) cell responses is likely to be an important requirement of vaccine candidates designed to prevent or moderate human immunodeficiency virus-1 (HIV-1) infection. We have investigated the ability of hybrid Ty virus-like particles carrying the V3 loop region of the HIV-1 IIIB envelope gp120 (V3:Ty-VLP) to elicit V3-specific proliferative responses. Significant proliferation in response to stimulation in vitro with homologous IIIB V3 peptide was observed following immunization of mice with V3:Ty-VLP either as an aluminium hydroxide precipitate or without adjuvant. Responses to MN V3 peptide were also observed in certain mouse haplotypes. To assess the effect of presenting the V3 loop in this particulate form, we compared the responses induced by V3:Ty-VLP with those obtained with two non-particulate immunogens, recombinant gp120 (rgp120) and V3 peptide conjugated to albumin. V3-specific responses to V3 peptide in vitro were reproducibly higher following immunization with V3:Ty-VLP than with either rgp120 or V3-albumin coagulate (V3-alb). The data indicate that immunization with the V3 loop as a hybrid Ty-VLP results in enhanced proliferative responses to V3 peptide and recognition of rgp120 in vitro. Some cross-reactivity of Th cells for V3 sequences from different isolates was also observed.
Similar articles
-
Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles.J Immunol. 1993 Jul 15;151(2):1097-107. J Immunol. 1993. PMID: 8335892
-
A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.J Pept Sci. 1996 May-Jun;2(3):165-75. doi: 10.1002/psc.54. J Pept Sci. 1996. PMID: 9231325
-
The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.Virology. 1998 Nov 10;251(1):59-70. doi: 10.1006/viro.1998.9392. Virology. 1998. PMID: 9813203
-
Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.Biol Chem. 1999 Mar;380(3):353-64. doi: 10.1515/BC.1999.047. Biol Chem. 1999. PMID: 10223338
-
Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses.J Biotechnol. 1996 Jan 26;44(1-3):203-7. doi: 10.1016/0168-1656(95)00151-4. J Biotechnol. 1996. PMID: 8717405 Review.
Cited by
-
Efficacy of AIDS vaccine strategies in nonhuman primates.Med Microbiol Immunol. 2005 Aug;194(4):201-6. doi: 10.1007/s00430-005-0238-5. Epub 2005 Apr 21. Med Microbiol Immunol. 2005. PMID: 15843997 Review.
-
Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles.Immunology. 1996 Feb;87(2):171-8. doi: 10.1046/j.1365-2567.1996.464539.x. Immunology. 1996. PMID: 8698376 Free PMC article.
-
Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies.Clin Exp Immunol. 1994 Sep;97(3):361-6. doi: 10.1111/j.1365-2249.1994.tb06095.x. Clin Exp Immunol. 1994. PMID: 7915974 Free PMC article.
-
Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion.J Virol. 1993 Jun;67(6):3191-8. doi: 10.1128/JVI.67.6.3191-3198.1993. J Virol. 1993. PMID: 8497047 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous